BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24049314)

  • 1. Alopecia due to cancer.
    Wiwanitkit S; Wiwanitkit V
    Indian J Med Paediatr Oncol; 2013 Apr; 34(2):141-2. PubMed ID: 24049314
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary Alopecia Neoplastica Mimicking Alopecia Areata following Breast Cancer.
    Skafida E; Triantafyllopoulou I; Flessas I; Liontos M; Koutsoukos K; Zagouri F; Dimopoulos AM
    Case Rep Oncol; 2020; 13(2):627-632. PubMed ID: 32774247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer.
    Werbel T; Cohen PR
    Cureus; 2018 Jul; 10(7):e3056. PubMed ID: 30280054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair disorders in cancer survivors.
    Freites-Martinez A; Shapiro J; van den Hurk C; Goldfarb S; Jimenez JJ; Rossi AM; Paus R; Lacouture ME
    J Am Acad Dermatol; 2019 May; 80(5):1199-1213. PubMed ID: 29660423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experience of chemotherapy-induced alopecia for Australian women with ovarian cancer.
    Jayde V; Boughton M; Blomfield P
    Eur J Cancer Care (Engl); 2013 Jul; 22(4):503-12. PubMed ID: 23528018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-related hair loss: a selective review of the alopecia research literature.
    Dua P; Heiland MF; Kracen AC; Deshields TL
    Psychooncology; 2017 Apr; 26(4):438-443. PubMed ID: 26594010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients.
    Choi EK; Kim IR; Chang O; Kang D; Nam SJ; Lee JE; Lee SK; Im YH; Park YH; Yang JH; Cho J
    Psychooncology; 2014 Oct; 23(10):1103-10. PubMed ID: 24664939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women with alopecia exhibit a higher risk for thyroid cancer: a nationwide cohort study.
    Sun LM; Lin MC; Muo CH; Liang JA; Sung FC; Kao CH
    J Dermatol Sci; 2014 Apr; 74(1):18-22. PubMed ID: 24439037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent associations between androgenetic alopecia and prostate cancer risk.
    Muller DC; Giles GG; Sinclair R; Hopper JL; English DR; Severi G
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):209-15. PubMed ID: 23074289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
    Hayes VM; Severi G; Eggleton SA; Padilla EJ; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):993-6. PubMed ID: 15824176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer.
    Park J; Kim JI; Yun SK; Kim HU; Ihm CW
    Ann Dermatol; 2014 Dec; 26(6):743-6. PubMed ID: 25473228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological sequelae and alopecia among women with cancer.
    McGarvey EL; Baum LD; Pinkerton RC; Rogers LM
    Cancer Pract; 2001; 9(6):283-9. PubMed ID: 11879330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.
    Freites-Martinez A; Shapiro J; Chan D; Fornier M; Modi S; Gajria D; Dusza S; Goldfarb S; Lacouture ME
    JAMA Dermatol; 2018 Jun; 154(6):670-675. PubMed ID: 29641806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male pattern baldness and the risk of prostate cancer.
    Yassa M; Saliou M; De Rycke Y; Hemery C; Henni M; Bachaud JM; Thiounn N; Cosset JM; Giraud P
    Ann Oncol; 2011 Aug; 22(8):1824-7. PubMed ID: 21324955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practitioner's guide to cancer-related alopecia.
    Dorr VJ
    Semin Oncol; 1998 Oct; 25(5):562-70. PubMed ID: 9783595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients.
    Ohsumi S; Kiyoto S; Takahashi M; Takashima S; Aogi K; Shimizu S; Doi M
    Support Care Cancer; 2021 Oct; 29(10):6119-6125. PubMed ID: 33797582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
    Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study.
    Kinoshita T; Nakayama T; Fukuma E; Inokuchi M; Ishiguro H; Ogo E; Kikuchi M; Jinno H; Yamazaki N; Toi M
    Front Oncol; 2019; 9():733. PubMed ID: 31448235
    [No Abstract]   [Full Text] [Related]  

  • 19. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study.
    Kang D; Kim IR; Choi EK; Im YH; Park YH; Ahn JS; Lee JE; Nam SJ; Lee HK; Park JH; Lee DY; Lacouture ME; Guallar E; Cho J
    Oncologist; 2019 Mar; 24(3):414-420. PubMed ID: 30120165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: a metaanalysis of four prospective randomised phase III trials with 5114 patients.
    Sehouli J; Fotopoulou C; Erol E; Richter R; Reuss A; Mahner S; Lauraine EP; Kristensen G; Herrstedt J; du Bois A; Pfisterer J
    Eur J Cancer; 2015 May; 51(7):825-32. PubMed ID: 25771433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.